Federica D’Angelo

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 290 citations

Medicine, Endocrinology, Pharmacology +11

Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study

Marilena Vitale, Olga Vaccaro, Maria Masulli et al. · Clinical Nutrition · 2016 · 78 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes)

Gian Paolo Fadini, Giancarlo Zatti, Agostino Consoli et al. · Nutrition Metabolism and Cardiovascular Diseases · 2017 · 30 citations

Medicine, Pharmacology, Diabetology +12

Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study

Gian Paolo Fadini, Daniele Bottigliengo, Federica D’Angelo et al. · Diabetes Therapy · 2018 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes

Veronica Sciannameo, Paola Berchialla, Angelo Avogaro et al. · Cardiovascular Diabetology · 2021 · 10 citations · Full text

Medicine, Biostatistics, Cardiology +16